Course overview:

Bone Turnover Markers (BTM) have long been used as diagnostic tests for metabolic bone diseases. In the past 20 years, markers that are more specific to bone have been introduced and have been found to be useful in osteoporosis, particularly for monitoring treatment. This course aims to provide a background to the clinical use of bone turnover markers.

Target audience:

This day-long course is open to clinicians (e.g. endocrinology, rheumatology, care of the elderly and clinical chemistry), laboratory scientists and nurses involved in the clinical management of patients at risk of osteoporotic fractures.

Objectives:

At the end of the course, participants should:

• understand the process of bone remodelling and how this can be studied using BTM
• appreciate the methods used for measuring BTM and their sources of variability
• be able to identify the role of BTM in the diagnosis and monitoring of bone diseases in a number of clinical settings including; osteoporosis, chronic kidney disease, Paget’s disease, osteomalacia, and GIOP
• be familiar with best practice in the clinical use of BTM

CME Accreditation:

An application will be made to the UEMS EACCME® for CME accreditation of the event.

Programme:

Please view the online programme here.

Registration:

The Training Course will be held during the Pre-Congress Day of the ECTS 2022 Annual Congress.

Registrations are available here, please select “Pre-Congress Day” in the registration process.

You can register in conjunction or separately from the ECTS 2022 Congress.

Costs:

• € 150,00 for ECTS Members
• € 200,00 for non Members
• € 100,00 in combination with ECTS 2022 congress registration

Registration to the Pre-Congress day will give you access to all other sessions of the day, with the exception of the Open Fora.

Course overview:

Up to one in five older people will have a vertebral fracture, but most are unaware of this. Such fractures can be diagnosed by spinal radiographs but more recently, the bone densitometer has been used for this purpose: vertebral fracture assessment. The use of this technique is increasing worldwide; this course aims to give a basic training on the identification of vertebral fractures.

Target audience:

This day-long course is open to clinicians, scan technicians and nurses involved in developing and delivering fracture risk assessment services.

Objectives:

At the end of the course, participants should:

• understand the importance of vertebral fracture identification
• understand the principles of good quality image acquisition
• be aware of the different methods used to identify vertebral fracture
• recognise non-fracture vertebral deformities
• recognise the clinical features of vertebral fracture

Programme:

The training course will be held within the ECTS 2021 Digital Congress Programme.

CME:

As part of the ECTS 2021 Digital Congress Programme, the training course is CME Accredited.

Participants can claim up to 8 European CME credits by the European Accreditation Council for Continuing Medical Education (EACCME®) for hours of credit that you have actually spent in the educational activity.

Registration:

The course is open to ECTS 2021 Digital Congress and ECTS@Home registered delegates.

>> Please let us know that you are joining by completing a short form.

>> Not an ECTS 2021 Digital Congress or ECTS@Home registered delegate?  It is not too late to join us, register here.

The 2020 ECTS-Mellanby Training Course on Diagnostic Tests for Osteoporosis is part of the ECTS Digital Congress Programme.  All ECTS 2020 delegates can attend for free the course. A separate registration is also available for non congress delegates at a very special rate of 50€ (including VAT).

The event will combine

• Pre-recorded talks that can be viewed at your own peace after 6 November 2020 and
• Live and Interactive workshops, panel discussions and Q&A on 17 November 2020 from 14:30 – 17:30 CET

Course overview:

Bone Turnover Markers (BTM) have long been used as diagnostic tests for metabolic bone diseases. In the past 20 years, markers that are more specific to bone have been introduced and have been found to be useful in osteoporosis, particularly for monitoring treatment. This course aims to provide a background to the clinical use of bone turnover markers.

Target audience:

This day-long course is open to clinicians (e.g. endocrinology, rheumatology, care of the elderly and clinical chemistry), laboratory scientists and nurses involved in the clinical management of patients at risk of osteoporotic fractures.

Objectives:

At the end of the course, participants should:

• understand the process of bone remodelling and how this can be studied using BTM
• appreciate the methods used for measuring BTM and their sources of variability
• be able to identify the role of BTM in the diagnosis and monitoring of bone diseases in a number of clinical settings including; osteoporosis, chronic kidney disease, Paget’s disease, osteomalacia, and GIOP
• be familiar with best practice in the clinical use of BTM

CME Accreditation:

An application has been made to the UEMS EACCME® for CME accreditation of the live event

Course overview:

Bone Turnover Markers (BTM) have long been used as diagnostic tests for metabolic bone diseases. In the past 20 years, markers that are more specific to bone have been introduced and have been found to be useful in osteoporosis, particularly for monitoring treatment. This course aims to provide a background to the clinical use of bone turnover markers.

Target audience:

This day-long course is open to clinicians (e.g. endocrinology, rheumatology, care of the elderly and clinical chemistry), laboratory scientists and nurses involved in the clinical management of patients at risk of osteoporotic fractures.

Objectives:

At the end of the course, participants should:

• understand the process of bone remodelling and how this can be studied using BTM
• appreciate the methods used for measuring BTM and their sources of variability
• be able to identify the role of BTM in the diagnosis and monitoring of bone diseases in a number of clinical settings including; osteoporosis, chronic kidney disease, Paget’s disease, osteomalacia, and GIOP,.
• be familiar with best practice in the clinical use of BTM

Endorsement and Accreditation:

Applications for credits points will be submitted to the Swiss Societies for Endocrinology, Internal Medicine, Rheumatology, Physical Medicine and Rehabilitation, Gynecology and Laboratory Medicine as well as the DVO (Dachverband deutschsprachiger osteologischer Gesellschaften). Endorsement will be sought from the Association for Endocrinology, Rheumatology, Clinical Biochemistry and Laboratory Medicine, the Swiss Society against Osteoporosis and the Swiss Bone and Mineral Society and the DVO.

Accomodation:

Hotel Basel
Münzgasse 12
4001 Basel
To receive the special rates, you have to book your rooms no later than 12 August 2019
• Modern Single Room: CHF 210
• Double Single room: CHF 240
*Rates are exclusive of Breakfast and City tax
To book your room contact the hotel directly by e-mail or telephone: +4161 264 68 00 and mention the Booking code: 190911 ECTS

Programme:

Chairman                 Richard Eastell (Sheffield, UK)

08:45-09:30            REGISTRATION AND COFFEE

09:30-09:35            BONE TURNOVER MARKERS: AN INTRODUCTION Richard Eastell (Sheffield, UK)

09:35-10:05            BONE REMODELLING AND THE INTERPRETATION OF BONE TURNOVER MARKER (BTM) RESULTS Richard Eastell (Sheffield, UK)

10:05-10:35            PRACTICAL ASPECTS OF MEASUREMENT AND SELECTION OF MARKER Marius Kraenzlin (Basel, CH)

10:35-11:05            SOURCES OF VARIABILITY IN BTM Christian Meier (Basel, CH)

 11:05-11:30            COFFEE BREAK

 11:30-12:00          USE OF BTM IN OSTEOPOROSIS: SHARED CARE PROTOCOLS IN PRIMARY CARE Jennie Walsh (Sheffield, UK)

12:00-13:00          INTERACTIVE WORKSHOPS

GROUP A: PROTOCOLS AND CASE EXAMPLES FOR THE USE OF BTM IN OSTEOPOROSIS PRACTICE
Jennie Walsh (Sheffield, UK), Christan Meier (Basel, CH)

GROUP B: USING BTM FOR OSTEOPOROSIS TREATMENT: RESEARCH APPLICATION
Marius Kraenzlin (Basel, CH), Richard Eastell (Sheffield, UK)

13:00-13:40            LUNCH

13:40-14:40            METABOLIC BONE DISEASES IN ADULTS Eugene McCloskey (Sheffield, UK)

14:40-15:30            METABOLIC BONE DISEASE OF CHRONIC KIDNEY DISORDER Barbara Obermayer-Pietsch (Graz, A)

15:30-15:50            COFFEE BREAK

15:50-16:50            INTERACTIVE WORKSHOPS

GROUP A: PROTOCOLS FOR THE USE OF BTM IN OSTEOPOROSIS PRACTICE
Jennie Walsh (Sheffield, UK), Christian Meier (Basel, CH)  

GROUP C: USING BTM IN METABOLIC BONE DISEASE
Barbara Obermayer-Pietsch (Graz, A), Eugene McCloskey (Sheffield, UK)

 17:10-17:30            EXPERT PANEL: QUESTIONS AND ANSWERS All speakers

 17:30                      CLOSE OF DAY

Our Sponsors:

We thank our sponsors for their support.  The event was supported by the following companies on the form of a sponsorship.  The scientific programme has not been influenced in any way by its sponsors.

Course overview:

Bone Turnover Markers (BTM) have long been used as diagnostic tests for metabolic bone diseases. In the past 20 years, markers that are more specific to bone have been introduced and have been found to be useful in osteoporosis, particularly for monitoring treatment. This course aims to provide a background to the clinical use of bone turnover markers.

Target audience:

This day–long course is open to clinicians (e.g. endocrinology, rheumatology, elderly care and clinical chemistry), laboratory scientists and nurses involved in the clinical management of patients at risk of osteoporotic fractures.

Objectives:

At the end of the course, participants should:
• understand the process of bone remodelling and how this can be studied using BTM
• appreciate the methods used for measuring BTM and their sources of variability
• be able to identify the role of BTM in the diagnosis and monitoring of bone diseases in a number of clinical settings including; osteoporosis, chronic kidney disease, Paget’s disease, osteomalacia, GIOP and PHPT.
• be familiar with best practice in the clinical use of BTM

Endorsement and CPD: Applications for CPD will be submitted to the Czech and Slovak national bodies.

More information